Curcumin's beneficial compounds in patented technology - Curcumin (commonly known as Turmeric)
One of the most investigated plants in biomedical research
Also known as turmeric, the root of the plant is a common spice in Indian and other Asian cuisines. It was introduced to the Western world in the 14th century
For 5000 years, the paste and extracts of the root have been used in Asia to treat a variety of ailments, from infections to inflammation, arthritis and cancer. The use continues to this day: dissolved in warm milk to fight off cough and cold, and digestive disorders; a paste applied to ward off pain, to heal wound and burns, and to treat skin diseases.
The condition occurs when the protective cartilage on the end of the bones wears down, causing joint pain and stiffness in the hands, knees, hips and spine. It is treated with different classes of pain killers, and steroids. Each one produces unwelcome side effects on the liver and kidney, GI and cardiovascular systems.
Unfortunately, curcumin in its naturally existing form is unstable and poorly soluble and isn’t well absorbed by the body, limiting its clinical benefits.
Curcumin is the subject of more than 3,000 pre-clinical investigations—more than 60 clinical trials are registered with the U.S. National Institutes of Health (NIH)—in conditions ranging from inflammation to arthritis, cancer, and diabetes.
Recent studies have produced a vast body of evidence of its beneficial effects in managing inflammation and osteoarthritis.
A number of formulations with delivery technology have been reported in recent years as offering a form of curcumin that is stable and highly absorbed by the body. One such delivery technology is the patented “phytosome” form MERIVA®  in which curcumin is safely tucked inside a commonly used fatty compound of soybean, lecithin, (a good dispersing agent used in pharmaceuticals) and delivered to the body’s cell membrane. This results is a 20-fold absorption over the normal curcumin.
Curcumin has no serious demonstrated side effects, and the increase in bioavailability does not translate into increased toxicity.
MERIVA® is a curcumin complex, its safety and efficacy supported by clinical trials. The studies show that
Paradigm Pharmaceuticals Inc., a New York, U.S.,
company offers dietary supplements along with
pharmaceuticals. It markets supplements whose
benefits are sufficiently supported by scientific
and clinical evidence to offer as natural and
It manufactures at GMP-certified plants, with each production batch tested and certified for the claimed composition and safety